These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28336184)

  • 1. Atrial fibrillation management in a breeding stallion.
    Heliczer N; Mitchell K; Lorello O; Dauvillier J; Burger D; Schwarzwald CC; Navas de Solis C
    J Vet Cardiol; 2017 Jun; 19(3):299-307. PubMed ID: 28336184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation.
    Decloedt A; Broux B; De Clercq D; Deprez P; Van Steenkiste G; Vera L; Ven S; van Loon G
    J Vet Intern Med; 2018 Mar; 32(2):815-821. PubMed ID: 29460446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECG of the Month. Persistent atrial tachycardia after cardioversion in a horse.
    Barrell EA; Fiorenza LR; Perkins GA; Kraus MS
    J Am Vet Med Assoc; 2015 Oct; 247(7):751-3. PubMed ID: 26383749
    [No Abstract]   [Full Text] [Related]  

  • 4. Atrial premature depolarisations five days post electrical cardioversion are related to atrial fibrillation recurrence risk in horses.
    Vernemmen I; De Clercq D; Decloedt A; Vera L; Van Steenkiste G; van Loon G
    Equine Vet J; 2020 May; 52(3):374-378. PubMed ID: 31583742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T).
    Atwood JE; Myers JN; Tang XC; Reda DJ; Singh SN; Singh BN
    Am Heart J; 2007 Apr; 153(4):566-72. PubMed ID: 17383295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of atrial function after cardioversion of atrial fibrillation in horses.
    Decloedt A; Verheyen T; Van Der Vekens N; Sys S; De Clercq D; van Loon G
    Vet J; 2013 Sep; 197(3):583-8. PubMed ID: 23823082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of biphasic electrical cardioversion for treatment of idiopathic atrial fibrillation in two horses.
    Frye MA; Selders CG; Mama KR; Wagner AE; Bright JM
    J Am Vet Med Assoc; 2002 Apr; 220(7):1039-45, 1007. PubMed ID: 12420784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation.
    Dan GA; Gonţa A
    Rom J Intern Med; 1997; 35(1-4):19-27. PubMed ID: 9562649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence.
    Vernemmen I; Van Steenkiste G; Dufourni A; Decloedt A; van Loon G
    J Vet Intern Med; 2022 Mar; 36(2):758-769. PubMed ID: 35246994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.
    Tse HF; Lau CP; Ayers GM
    Heart; 1999 Sep; 82(3):319-24. PubMed ID: 10455082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm.
    Decloedt A; Schwarzwald CC; De Clercq D; Van Der Vekens N; Pardon B; Reef VB; van Loon G
    J Vet Intern Med; 2015; 29(3):946-53. PubMed ID: 25917409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation in horses Part 2: Diagnosis, treatment and prognosis.
    Decloedt A; Van Steenkiste G; Vera L; Buhl R; van Loon G
    Vet J; 2021 Feb; 268():105594. PubMed ID: 33468306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Arrhythmias in Horses.
    van Loon G
    Vet Clin North Am Equine Pract; 2019 Apr; 35(1):85-102. PubMed ID: 30871832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial.
    Lombardi F; Borggrefe M; Ruzyllo W; Lüderitz B;
    Eur Heart J; 2006 Sep; 27(18):2224-31. PubMed ID: 16935870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Atrial fibrillation in horses: new treatment choices for the new millennium?
    Young L; van Loon G
    J Vet Intern Med; 2005; 19(5):631-2. PubMed ID: 16231706
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantification of left atrial contractile function using two-dimensional speckle tracking echocardiography in horses after conversion of atrial fibrillation to sinus rhythm.
    Eberhardt C; Schwarzwald CC
    J Vet Cardiol; 2021 Jun; 35():108-120. PubMed ID: 33940552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECG of the month. Ventricular tachycardia in a horse.
    Johnson AL; Jesty SA; Gelzer AR; Divers TJ; Kraus MS
    J Am Vet Med Assoc; 2007 Sep; 231(5):706-8. PubMed ID: 17764427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.